Potassium Chloride Tablet, Extended Release
Product Images NDC 72888-099

Each extended-release tablet provides potassium chloride, USP 750 mg (equivalent to 10 mEq potassium). The usual dosage must be adjusted to the individual needs of each patient. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). They should be protected from light and moisture and dispensed in a tight, light-resistant container with a child-resistant closure. This medication is FDA approved and comes in a package containing 1000 tablets. It is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. Please refer to the package insert for full prescribing information.*

This text appears to be a description of a medication called Potassium Chloride Extended-Release Tablets. Each tablet provides 750 mg of potassium chloride, which is equivalent to 10 mEq of potassium. The usual dosage and other prescribing information can be found in the package insert. The tablets should be stored at a temperature between 20° to 25° Celsius and protected from light and moisture. They should be dispensed in a tightly sealed container with child-resistant closure. The medication is FDA approved and distributed by Advagen Pharma Limited in Plainsboro, NJ, USA. It is manufactured by Rubicon Research Private Limited in Ambernath, India.*

This is a description of a medication called Potassium Chloride Extended-Release Tablets. Each tablet contains 1125 mg of potassium chloride, equivalent to 15 milliequivalents (mEq) of potassium. The dosage must be adjusted based on individual needs. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C to 30°C (59°F to 86°F). It is important to protect the tablets from light and moisture by storing them in a tightly sealed, light-resistant container with a child-resistant closure. The medication should be kept out of the reach of children. The FDA has different acceptance criteria for the assay compared to the USP test. The medication is approved for prescription use and comes in a pack of 1000 tablets. The manufacturer is Advagen Pharma Limited, located at 666 Plainsboro Road Suite 605, Plainsboro, NJ. The tablets are manufactured by Rubicon Research Private Limited in Ambernath, India. The manufacturing license number is KD-682.*

This text is a description of potassium chloride extended-release tablets. Each tablet contains 1125 mg of potassium chloride, equivalent to 15 mEq of potassium. The usual dosage and prescribing information is not provided and should be referred to the package insert. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F), with excursions allowed to 15° to 30°C (59° to 86°F). They should be protected from light and moisture and dispensed in a tight, light-resistant container with a child-resistant closure. The product is FDA approved, and the manufacturer information is provided. The NDC (National Drug Code) number for the product is 72888-098-01.*

This is a description for potassium chloride extended-release tablets. Each tablet provides 1500 mg of potassium chloride, which is equivalent to 20 mEq of potassium. The usual dosage should be determined based on the individual needs of each patient. The tablets should be stored at a temperature of 20° to 25°C, with excursions permitted between 15° to 30°C. They should be protected from light and moisture and dispensed in a tight, light-resistant container with a child-resistant closure. These tablets are FDA approved, and the manufacturer is Advagen Pharma Limited, located in Plainsboro, NJ, USA. They are distributed by Rubicon Research Private Limited in India.*

This is a description of a medication called Potassium Chloride Extended-Release Tablets, USP. Each tablet contains 1500 mg of potassium chloride, which is equivalent to 20 milliequivalents of potassium. The dosage is to be adjusted based on the individual needs of each patient. The tablets should be stored at a temperature between 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). It is important to protect the tablets from light and moisture by dispensing them in a tight, light-resistant container with a child-resistant closure. This medication is only available with a prescription and is distributed by Advagen Pharma Limited in Plainsboro, NJ, USA. The tablets are manufactured by Rubicon Research Private Limited in India.*